Lantheus Holdings (LNTH) Invested Capital (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Invested Capital came in at $803000.0 in Q1 2026, up 7.5% year-on-year from $747000.0 in Q1 2025, and up 8.81% on a QoQ basis from $738000.0 in Q4 2025.
Lantheus Holdings (LNTH) Invested Capital (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Invested Capital data on file, last reported at $803000.0 in Q1 2026.
- On a quarterly basis, Invested Capital rose 7.5% year-over-year to $803000.0 in Q1 2026; TTM through Mar 2026 was $3.2 million, a 99.43% decrease from a year earlier, with the FY2025 full-year figure at $738000.0, down 24.23% from the prior year.
- Invested Capital for Q1 2026 stood at $803000.0, up from $738000.0 in the prior quarter.
- Over the last five years, Invested Capital for LNTH reached as high as $564.7 million in Q3 2024 and fell as low as $384000.0 in Q2 2023.
- Historically, Invested Capital has averaged $42.1 million across 5 years, with a median of $823000.0 in 2023.
- Across the five-year window, Invested Capital surged 80229.02% in 2024 and tumbled 99.85% in 2025, its largest moves.
- Year by year, Invested Capital stood at $99.7 million in 2022, then plunged by 99.17% to $823000.0 in 2023, then advanced by 18.35% to $974000.0 in 2024, then declined by 24.23% to $738000.0 in 2025, then increased by 8.81% to $803000.0 in 2026.
- Per Business Quant data, the three most recent Invested Capital figures were $803000.0 in Q1 2026, $738000.0 in Q4 2025, and $871000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 803,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 803,000.00 |
| Dec 31, 2025 | 738,000.00 |
| Sep 30, 2025 | 871,000.00 |
| Jun 30, 2025 | 796,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 564.71 Mn |
| Jun 30, 2024 | 868,000.00 |
| Mar 31, 2024 | 734,000.00 |
| Dec 31, 2023 | 823,000.00 |
| Sep 30, 2023 | 703,000.00 |
| Jun 30, 2023 | 384,000.00 |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 99.70 Mn |
| Sep 30, 2022 | 15.37 Mn |
| Jun 30, 2022 | 14.07 Mn |
| Mar 31, 2022 | 12.88 Mn |
| Dec 31, 2021 | 11.64 Mn |
| Sep 30, 2021 | 10.36 Mn |
| Jun 30, 2021 | 10.37 Mn |